Diferencias en los resultados quirúrgicos en pacientes con anemia preoperatoria tratada con hierro o sin hierro previo a la cirugía

  1. Francisco Javier García Sánchez 1
  2. Almudena Nieto Ramos 2
  3. Natalia Mudarra García 1
  1. 1 Doctor/a por la Universidad Complutense de Madrid (UCM). Unidad de Prehabilitación Quirúrgica. Hospital Universitario Infanta Cristina. Departamento de Medicina. Facultad de Medicina. UCM. IDIPHISA. Madrid (España)
  2. 2 Enfermera. Consulta de Prehabilitación Quirúrgica. Hospital Universitario Infanta Cristina. Parla, Madrid (España)
Journal:
Metas de enfermería

ISSN: 1138-7262

Year of publication: 2023

Volume: 26

Issue: 9

Pages: 59-65

Type: Article

DOI: 10.35667/METASENF.2023.26.1003082178 DIALNET GOOGLE SCHOLAR

More publications in: Metas de enfermería

Metrics

Cited by

  • Scopus Cited by: 0 (27-01-2024)
  • Dimensions Cited by: 0 (11-02-2024)

SCImago Journal Rank

(Indicator corresponding to the last year available on this portal, year 2022)
  • Year 2022
  • SJR Journal Impact: 0.112
  • Best Quartile: Q4
  • Area: Nursing (miscellaneous) Quartile: Q4 Rank in area: 151/161

Índice Dialnet de Revistas

(Indicator corresponding to the last year available on this portal, year 2022)
  • Year 2022
  • Journal Impact: 0.070
  • Field: ENFERMERÍA Quartile: C2 Rank in field: 18/43

Scopus CiteScore

(Indicator corresponding to the last year available on this portal, year 2022)
  • Year 2022
  • CiteScore of the Journal : 0.2
  • Area: Nursing (all) Percentile: 4

Dimensions

(Data updated as of 11-02-2024)
  • Total citations: 0
  • Recent citations (2 years): 0

Abstract

Objectives: to understand the differences in surgical results in patients with preoperative anemia treated with Ferric carboxymaltose (FCM) or without iron before surgery. Methods: a retrospective observational study of two patient cohorts: a Group without preoperative FCM (before the implementation of the Surgical Prehabilitation program), and a Group with FCM (after the implementation of the program). A review of electronic clinical records; the outcome variables were the number of transfusions of blood products required after surgery, postsurgical complications, and days of hospital stay. There was a comparison of study variables through Chi square and Student’s t tests; the SPSS statistical program, v. 26, was used. Results: the study included 152 patients, 92 in the FCM Group (2020-2022) and 56 in the Group without FCM (2019); 60.5% (n= 92) were female. Their mean age (standard deviation) was 63.91 (13) years. The surgical procedures included were: colectomy (n= 77; 64.5%), mastectomy (n= 55; 23%) and hysterectomy (n= 20; 12.5%). Statistically significant outcomes were found between the need for blood transfusions (p< 0.001; OR 15.91 (4.44-57.01)), postsurgical complications (p< 0.001; OR 7.36 (3.35-16.16)), and the mean hospital stay (p< 0.001), which was 4.14 days in the FCM group vs. nine days in the control group without FCM. Conclusions: treatment with FCM reduced the number of blood transfusions, postsurgical complications, and days of hospital stay.